Stay updated with breaking news from ஜான் மக்மரே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long Island Fishing Report – September 16, 2021 onthewater.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onthewater.com Daily Mail and Mail on Sunday newspapers.
July 27, 2021 MIAMI, FL A debate at TVT 2021 last week was supposed to be about whether guideline-directed medical therapy should be tried at maximally tolerated doses before patients undergo transcatheter edge-to-edge repair (TEER) for functional mitral regurgitation (MR), but it ended up focusing on the difficulty of getting patients on foundational heart failure therapies in the first place. JoAnn Lindenfeld, MD (Vanderbilt Heart and Vascular Institute, Nashville, TN), led off by arguing that drug therapy should be maxed out first, but her ostensible opponent didn’t disagree. “I want to concede the debate to JoAnn. I think she made a convincing argument, and I really don’t have much to add to what she said,” Milton Packer, MD (Baylor Heart and Vascular Institute, Houston, TX), said. ....
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Schumer urges expedited dredging of Jones Beach Inlet newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.
email article One theory for why the medications tested in heart failure with preserved ejection fraction (HFpEF) trials have not shown efficacy: inclusion of too many unrecognized cases of cardiac amyloidosis (CA). The specific hemodynamic and pathophysiological features of CA result in poor tolerance of heart failure medications and in worse outcomes compared with other causes of heart failure, according to Silvia Oghina, MD, of Hôpital Henri-Mondor in Créteil, France, and colleagues. Studies have shown CA in up to 29% of patients with HFpEF. This finding is unsurprising, as criteria used to diagnose HFpEF include the presence by echocardiography of left ventricular hypertrophy with left atrial enlargement and/or diastolic dysfunction, which are typical features of CA, they wrote in a state-of-the-art paper published online in ....